The global valeryl chloride market size stood at US$ 551.25 Million in the year 2022 and is expected to reach US$ 898 Million by the year 2032 at a CAGR of 5% between 2022 and 2032. Coming to the electronics vertical, valeryl chloride is used in semiconductors and LCDs (liquid crystal displays). Coming back to the pharmaceuticals …
Monthly Archives: February 2024
Global Meningococcal Meningitis Treatment Industry Trajectory, Envisioning US$ 283 Million Valuation with a 4.7% CAGR by 2033 | FMI
The Global Meningococcal Meningitis Treatment Industry has a market value of US$ 170.75 Million in 2022 and is predicted to have a market value of US$ 283 Million by 2023 to 2033, at a CAGR of 4.7%. Meningococcal Meningitis treatment market growth can be attributable to illness prevalence, increased vaccine availability, and increased disease awareness. From …
Global Gastroesophageal Junction Adenocarcinoma Therapeutics Industry Targets Astounding 18% CAGR Advancement, Projecting a US$ 34.3 Billion Landscape by 2033 | FMI
Future Market Insights has revealed a promising trajectory for the Global Gastroesophageal Junction Adenocarcinoma Therapeutics Industry, forecasting an impressive 18% Compound Annual Growth Rate (CAGR) during the period from 2023 to 2033. By 2033, the global market for GEJAC Therapeutics is poised to reach an extraordinary valuation of US$ 34.3 Billion, reflecting a paradigm shift …
Global Chronic Pulmonary Hypertension Treatment Industry to Expand Significantly, Forecasted to Hit US$ 11.4 Billion by 2033 | FMI
Future Market Insights, a leading market research firm, has recently released a comprehensive study forecasting a significant surge in the Global Chronic Pulmonary Hypertension Treatment Industry. The market, currently valued at US$ 7 billion in 2023, is expected to witness a robust CAGR of 5%, reaching a remarkable US$ 11.4 billion by the year 2033. …
Global Birch Allergy Treatment Industry Predicted to Expand at 7% CAGR, Anticipating US$ 1123.24 Million Value by 2033 | FMI
During the forecast period from 2023 to 2033, the Global Birch Allergy Treatment Industry is poised for substantial growth at a 7% Compound Annual Growth Rate (CAGR), as reported by Future Market Insights. By the year 2033, the global market for Birch allergy treatment is expected to reach a remarkable valuation of US$ 1123.24 Million. …
Global Pediatric Obesity Management Industry Set for 4% CAGR, Envisioned at US$ 4.74 Billion by 2033 | FMI
The Global Pediatric Obesity Management Industry is reaching new heights, emerging as a paramount concern in public health. Recent data from the World Health Organization (WHO) reveals a staggering reality, with approximately 41 million children under the age of five identified as overweight or obese in 2016. Alarming as it is, projections indicate a continued …
Global Nipah Virus (NiV) Infection Testing Industry Eyes Noteworthy 5.2% Growth, Aiming for US$ 3,277.49 Million by 2033 | FMI
The Global Nipah Virus (Niv) Infection Testing Industry is poised for substantial growth during the forecast period from 2023 to 2033, with a projected Compound Annual Growth Rate (CAGR) of 5.2%, according to the latest analysis by Future Market Insights. By 2033, the market is anticipated to reach a staggering valuation of US$ 3,277.49 million. …
Global Migraine Treatment Industry to Achieve US$ 4.74 Billion by 2033, Propelled by a Steady 4% Compound Annual Growth Rate | FMI
The Global Migraine Treatments Industry is on the brink of a significant upswing, fuelled by heightened awareness of the condition and notable advancements in treatment options. According to a comprehensive report by Future Market Insights, the market is anticipated to experience a steady compound annual growth rate (CAGR) of 4% from 2023 to 2033. Migraine, …
Global Glucose Monitoring Devices Industry Achieves Unprecedented Growth at 16.9% CAGR, set to Surpass US$ 118.1 Billion by 2033 | FMI Reports
According to the latest industry report from Future Market Insights (FMI), the Global Glucose Monitoring Devices Industry, valued at approximately US$ 21.3 Billion in 2022, is poised for remarkable growth, projecting a Compound Annual Growth Rate (CAGR) of nearly 16.9% over the forecast period. FMI anticipates the industry to achieve a staggering estimated worth of …
Global Gene Therapy in CNS Disorder Industry to Hit a Record US$113.04 Billion by 2033, Driven by remarkable a 30% CAGR | FMI Findings
The Global Gene Therapy in CNS Disorder Industry is poised for an unprecedented surge, with projections indicating a remarkable growth trajectory. According to industry forecasts, the market is expected to achieve a value of US$ 8.2 billion in 2023, catapulting to an astounding US$ 113.04 billion by 2033. This remarkable ascent is underpinned by a …